We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based ... read more Featured Products: More products

Download Mobile App




Rapid Methods Compared for Positive Blood Cultures

By LabMedica International staff writers
Posted on 20 May 2014
The need for rapid antibiotic treatment of sepsis is well recognized, and the time to implementation of appropriate antibiotic therapy is critical in improving the outcome of sepsis.

Several methods have been developed to identify pathogens and some antibiotic resistance genes directly from positive blood culture bottles, which can shorten the time for final identification and susceptibility by as much as one to two days.

Medical laboratory scientists at the University of Florida (Gainesville, FL, USA) directly compared a multiplex polymerase chain reaction (PCR) method with a mass spectrometry system to identify organisms in positive blood cultures, between October 2012 and May 2013. More...
They analyzed fluid from 161 positive blood cultures by both methods within 2 to 12 hours of the time the culture signaled positive in BacTec plus aerobic/F bottles incubated in a BacTec 9240 instrument (Becton, Dickinson and Company; Franklin Lakes, NJ, USA).

The two methods used to identify the bacteria were the FilmArray Direct from Positive Blood Culture system (BCID) (BioFire Diagnostics, Salt Lake City, UT, USA) and the VITEK Mass Spectrometry System (Vitek MS, bioMérieux; Durham, NC, USA). The BCID uses multiplex PCR to identify 90% to 95% of common isolates to the genus or species/complex level as well as three antibiotic resistance genes in approximately one hour. The prepared slides for the Vitek MS system were run in a bioMérieux mass spectrometer (Marcy l’Etoile, France).

A total of 132/133 (99%) of isolates that were in the FilmArray panel were identified correctly to the genus and/or species level. For those organisms that the FilmArray could identify to the species or species/complex level, 84/84 (100%) were correctly identified; for those that would only be expected to be identified to the genus level, 48/49 (98%) were identified correctly. The turnaround time for an individual FilmArray test is about an hour and if multiple samples need to be run, multiple instruments may be necessary.

Mass spectrometry correctly identified 142/151 (94%) monomicrobic cultures to the genus level and 137/151 (91%) to the species level. Vitek MS can process up to 48 specimens per slide in approximately an hour, but the actual time to perform a direct identification from a positive blood culture bottle would depend both on the filtration time and the workflow in the clinical microbiology setting to set up the slide and be read in the mass spectrometer.

The authors concluded that both the FilmArray and the VITEK MS mass spectrometry systems were highly accurate and can provide results in about an hour after blood cultures become positive, but the FilmArray is far easier to perform and to incorporate into laboratory workflow. The study was published online on March 22, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of Florida
Becton, Dickinson and Company
BioFire Diagnostics



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.